Vaccizone logo — Exploring advanced techniques for antigen delivery in modern...

Vaccizone

Exploring advanced techniques for antigen delivery in modern medicine.

Founded 2019 Turkey Turkey 4 employees Angel Biotechnology, Manufacturing +1

General Information

Company Name Vaccizone
Founded Year 2019
Location Turkey Turkey
Employees 4
Industries Biotechnology, Manufacturing, Pharmaceutical
Funding Stage Angel
Social

Get notified when Vaccizone moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vaccizone

Vaccizone is a biotechnology startup that focuses on exploring advanced techniques for antigen delivery in modern medicine. The company's slogan emphasizes its commitment to developing innovative approaches to enhance the immune system's response against cancer, with the aim of improving treatment efficacy and patient outcomes. Since its establishment in 2019, Vaccizone has been working on technologies for precise antigen delivery, which hold significant promise in the fight against cancer.

Based in Turkey, Vaccizone operates within the Biotechnology, Manufacturing, and Pharmaceutical industries. The startup recently received an Angel Round investment on 28 May 2021, with Keiretsu Forum Turkey being the participating investors. This injection of funding is expected to further support the company's research and development efforts, as well as its overall growth trajectory within the biotech sector.

Taxonomy: Antigen Delivery, Cancer Immunotherapy, Vaccine Technologies, ASC Technology, Treatment Development, Immunotherapy, Disease Prevention, Innovative Therapies

Services & Products

Next generation antigen delivery and vaccine technologies for human and animal diseases

Target Customers

Pharmaceutical companies research institutions veterinary clinics healthcare organizations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round •••••• 1
Investor
28 May 2021

Vaccizone Alternatives & Competitors

Vaccizone vs
Apexigen
Apexigen United States

Creating Transformative Immunotherapies for Patients with Cancer

Post Ipo Equity
11 employees
Biopharma, Biotechnology
Vaccizone vs

A new frontier in the fight against cancer– the right activation of the right immune cells

Series B
41 employees
Health Care
Vaccizone vs

Eureka Therapeutics is a privately held biotechnology company located in the San Francisco Bay Area,...

Grant
45 employees
Biotechnology, Health Care

FAQ About Vaccizone

Exploring advanced techniques for antigen delivery in modern medicine.
Vaccizone was founded in 2019.
Vaccizone is headquartered in Turkey.
Vaccizone operates in the following industries: Biotechnology, Manufacturing, Pharmaceutical.
Vaccizone has approximately 4 employees.
Vaccizone has completed 1 funding round. The latest funding stage is Angel.
Vaccizone offers: Next generation antigen delivery and vaccine technologies for human and animal diseases.
Top alternatives and competitors to Vaccizone include Apexigen, Marengo Therapeutics, Eureka Therapeutics, Inc, Rebirthel Co.,Ltd., Seven and Eight Biopharmaceuticals Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vaccizone and Apexigen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vaccizone and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy